In a preclinical model of spontaneous prostate cancer, tumor growth was significantly suppressed in CXCR2-deficient mice compared with controls, with a corresponding reduction in tumor angiogenesis as measured by von Willebrand factor RNA expression (78). This evidence concerns the gene VWF and neoplasm.